Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP424705.RAbDgG2p_n5T5S6YmGXsl0FOXnM5E8u6OEokBbdc2UVX8130_assertion description "[Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424705.RAbDgG2p_n5T5S6YmGXsl0FOXnM5E8u6OEokBbdc2UVX8130_provenance.
• assertion description "[Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP282754.RAZxRBWNdJRSQSFA382sUp5hCosd6X7HMYdUes8s9UGRE130_assertion description "[Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282754.RAZxRBWNdJRSQSFA382sUp5hCosd6X7HMYdUes8s9UGRE130_provenance.
• NP972415.RAbt4Up15MVptjltW0S8D-tUv9eNRDYpiNfvF8aVRyksw130_assertion description "[Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP972415.RAbt4Up15MVptjltW0S8D-tUv9eNRDYpiNfvF8aVRyksw130_provenance.
• assertion description "[Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP393396.RAZLlQBTFDnO05nAOLynsi0wCWHWeMC-Xy3pvueYJhxfQ130_assertion description "[Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393396.RAZLlQBTFDnO05nAOLynsi0wCWHWeMC-Xy3pvueYJhxfQ130_provenance.
• NP393397.RAVBhUbSXKrTS7pdPF_uc9IztILTLSVf2g2f1OK5XzhSY130_assertion description "[Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393397.RAVBhUbSXKrTS7pdPF_uc9IztILTLSVf2g2f1OK5XzhSY130_provenance.
• NP393398.RAxzmJ7-DrXNK4hcLNiIazfcCL9J3VwZSpZgGitFd-4Cg130_assertion description "[Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393398.RAxzmJ7-DrXNK4hcLNiIazfcCL9J3VwZSpZgGitFd-4Cg130_provenance.
• NP393401.RA05b2wucTFMmx1dtEwWcBABIM1SmbdL99kGHdbHgtwJ0130_assertion description "[Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393401.RA05b2wucTFMmx1dtEwWcBABIM1SmbdL99kGHdbHgtwJ0130_provenance.